Pay in 4 interest-free payments of $6.56 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Treatment should be initiated with parenteral hydroxocobalamin without delay in cases of cobalamin C defect, as in any suspected remethylation disorder, because it significantly improves survival and incidence of severe complications (101)
First, there is no human clinical trial of AHK-Cu by any route injectable or topical and the entire peer-reviewed evidence specific to this peptide is a single 2007 study that was ex vivo (isolated human hair follicles) and in vitro (cultured dermal-papilla cells) [1]
Notably, the compound is stable across a wide pH range and fully soluble in aqueous media, unusual properties for a peptide of this size that are attributed to its high proportion of proline and charged residues
In short, as far as BPC 157s effectiveness is concerned, injections are superior to oral or nasal administration when it comes to sports injuries
Its possible, though not well-documented yet
GLP-compliant testing is the standard required for data submitted to regulatory agencies to support safety or efficacy claims
